Ftse Mib
34.249,77
0,91%
DAX
18.161,01
1,32%
S&P 500
5.099,96
1,02%
NASDAQ Composite
15.927,90
2,03%
Bitcoin
62.985,16
-1,18%

Quotazioni in diretta

Non abbiamo trovato risultati per:
Assicurati di aver scritto correttamente o prova ad allargare la ricerca.

Più Attivi

Toplist

Sembra che tu non sia connesso.
Clicca il pulsante qui sotto per accedere e visualizzare la tua cronologia recente.

Registrati

Sei già registrato? Accedi

Pepperstone

Inizia Ora

Pepperstone
Assistenza
Home Investire Azioni U.S.A. NASDAQ Sangamo Therapeutics Inc (SGMO) Sangamo Therapeutics Inc (SGMO) Notizie

Sangamo Therapeutics Inc

SGMO
0,5101
0,0071 (1,41%)
27 Apr 2024 - Chiuso
Dati in Delay di 15 minuti
Borsa: NASDAQ
Tipo: Azione
Valuta: USD

Ultime notizie

Data Ora Fonte Titolo
22/4/202422:35BWSangamo Therapeutics to Present Neurology-Focused..
22/3/202413:05BWSangamo Therapeutics Announces Pricing of $24.0 Million..
13/3/202413:05BWSangamo Therapeutics Reports Recent Business Highlights and..
13/3/202413:01BWSangamo Therapeutics Announces Data From Novel Proprietary..
12/3/202423:30BWSangamo Therapeutics Announces Fourth Quarter and Full Year..
27/2/202423:14EDGAR2Form 4 - Statement of changes in beneficial ownership of..
27/2/202423:13EDGAR2Form 4 - Statement of changes in beneficial ownership of..
27/2/202423:13EDGAR2Form 4 - Statement of changes in beneficial ownership of..
27/2/202423:12EDGAR2Form 4 - Statement of changes in beneficial ownership of..
27/2/202423:11EDGAR2Form 4 - Statement of changes in beneficial ownership of..
12/2/202414:05BWSangamo Therapeutics Announces U.S. FDA Alignment on..
06/2/202422:35EDGAR2Form 8-K - Current report
06/2/202400:01BWSangamo Therapeutics Announces Updated Phase 1/2 STAAR Study..
26/1/202417:49EDGAR2Form SC 13G/A - Statement of acquisition of beneficial..
24/1/202422:42EDGAR2Form 4 - Statement of changes in beneficial ownership of..
24/1/202422:42EDGAR2Form 4 - Statement of changes in beneficial ownership of..
24/1/202422:41EDGAR2Form 4 - Statement of changes in beneficial ownership of..
24/1/202422:40EDGAR2Form 4 - Statement of changes in beneficial ownership of..
24/1/202422:39EDGAR2Form 4 - Statement of changes in beneficial ownership of..
19/1/202423:09EDGAR2Form 8-K - Current report
13/12/202313:55EDGAR2Form 8-K - Current report
28/11/202322:20EDGAR2Form 4 - Statement of changes in beneficial ownership of..
28/11/202322:19EDGAR2Form 4 - Statement of changes in beneficial ownership of..
28/11/202322:19EDGAR2Form 4 - Statement of changes in beneficial ownership of..
28/11/202322:18EDGAR2Form 4 - Statement of changes in beneficial ownership of..
28/11/202322:17EDGAR2Form 4 - Statement of changes in beneficial ownership of..
28/11/202322:16EDGAR2Form 4 - Statement of changes in beneficial ownership of..
28/11/202322:15EDGAR2Form 4 - Statement of changes in beneficial ownership of..
03/11/202321:02EDGAR2Form 8-K - Current report
01/11/202321:17EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
01/11/202321:02EDGAR2Form 8-K - Current report
01/11/202321:01BWSangamo Therapeutics Announces Strategic Update and Reports..
25/10/202322:15BWSangamo Therapeutics Announces Third Quarter 2023 Conference..
24/10/202308:01BWSangamo Therapeutics to Present Pre-Clinical Data Showcasing..
20/9/202322:15BWSangamo Therapeutics to Present at the Jefferies Cell &..
29/8/202322:15EDGAR2Form 4 - Statement of changes in beneficial ownership of..
29/8/202322:15EDGAR2Form 4 - Statement of changes in beneficial ownership of..
29/8/202322:14EDGAR2Form 4 - Statement of changes in beneficial ownership of..
29/8/202322:13EDGAR2Form 4 - Statement of changes in beneficial ownership of..
29/8/202322:13EDGAR2Form 4 - Statement of changes in beneficial ownership of..
29/8/202322:12EDGAR2Form 4 - Statement of changes in beneficial ownership of..
15/8/202322:55EDGAR2Form 4 - Statement of changes in beneficial ownership of..
08/8/202322:47EDGAR2Form S-8 - Securities to be offered to employees in employee..
08/8/202322:15EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
08/8/202322:08EDGAR2Form 8-K - Current report
08/8/202322:01BWSangamo Therapeutics Reports Recent Business Highlights and..
01/8/202322:15BWSangamo Therapeutics Announces Second Quarter 2023..
20/7/202314:05BWSangamo Therapeutics and Chroma Medicine Announce Option and..
17/7/202314:05BWSangamo Therapeutics Announces Research Evaluation and..
29/6/202314:05BWSangamo Therapeutics and Voyager Therapeutics Enter License..
Apertura: 0,52 Min: 0,503 Max: 0,5339
Chiusura: 0,503

La tua Cronologia

NASDAQ
SGMO
Sangamo Therapeutics
Delayed Upgrade Clock

Il sito ADVFN Italia è stato realizzato ed è gestito da PRODESFIN su licenza di ADVFN PLC.

PER CONTATTI E PUBBLICITA' CLICCA QUI

Accedendo ai servizi offerti da ADVFN, ne si accettano le condizioni generali Termini & Condizioni

ADVFN Network